Blog

3Jul

The RELIEVE IBS-D clinical trial, which is testing the efficacy of the intestinal adsorbent ENTEROSGEL to treat diarrhoea and abdominal pain in patients with Irritable bowel syndrome with diarrhoea (IBS-D) has so far successfully recruited 105 patients.

This large Randomised Placebo-Controlled trial aims to recruit 430 patients over the next 12 months from 28 hospital and GP surgeries in England. The study has been designed with help from patients and includes an easy to use electronic daily diary which takes just minutes to complete and an open-label phase where every patient gets to try Enterosgel treatment.

Patient back on the trial has been great, one patient said “I have had amazing results from the Enterosgel trial, I can’t believe that drinking something twice a day can have such an effect on your digestive system…”

For more information and where to find your nearest participating site, visit the trial website:

Congratulations to the ContactME-IBS research registry on registering their 2000th patient.  If you’re interested in getting involved visit

  

talkhealth

This is the talkhealth blog spot, where we post on a wide range of health conditions, topics, issues and concerns. We post when we see something that we believe is of interest to our vistiors. Our posts do not reflect any particular view or stand point of talkhealth, but are merely to raise attention and awareness.

Add a comment